Global Bio-chem Technology Group Co (HKSE:00809) Change In Working Capital : HK$292 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Global Bio-chem Technology Group Co Change In Working Capital?

Global Bio-chem Technology Group Co's change in working capital for the quarter that ended in Dec. 2023 was HK$238 Mil.

Global Bio-chem Technology Group Co's change in working capital for the fiscal year that ended in Dec. 2023 was HK$292 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Global Bio-chem Technology Group Co Change In Working Capital Historical Data

The historical data trend for Global Bio-chem Technology Group Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Bio-chem Technology Group Co Change In Working Capital Chart

Global Bio-chem Technology Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

1,010.62

566.33

38.11

413.91

291.85

Global Bio-chem Technology Group Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															280.05	312.60	101.31	54.14	237.72

Global Bio-chem Technology Group Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$292 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Global Bio-chem Technology Group Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Global Bio-chem Technology Group Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Bio-chem Technology Group Co (HKSE:00809) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Global Bio-chem Technology Group Co Ltd (HKSE:00809) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Hung Luen Road, Suite 1002, 10th Floor, Tower A, Cheung Kei Center, Hung Hom, Kowloon, Hong Kong, HKG

Website

http://www.globalbiochem.com

Global Bio-chem Technology Group Co Ltd manufactures and sells corn-refined products and corn-based biochemical products. Its segments are the Upstream Products segment engages in the manufacture and sale of corn starch, gluten meal, corn oil, and other corn refined products; the Amino Acids segment engages in the manufacture and sale of corn-based biochemical products, including lysine and threonine; the Corn Sweeteners segment engages in the manufacture and sale of corn-based sweetener products, including glucose, maltose, high fructose corn syrup, crystallized glucose, and maltodextrin; the Polyol Chemicals segment engages in the manufacture and sale of corn-based biochemical products, including polyol chemicals, anti-freeze products, hydrogen, and ammonia.

Executives

Ji Lin Sheng Ren Min Zheng Fu Guo You Zi Chan Jian Du Guan Li Wei Yuan Hui	2201 Interest of corporation controlled by you
Ji Lin Sheng Yuan Heng Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Ji Lin Sheng Li Heng Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Ji Lin Zhang Bai Shan Gu Quan Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Ji Lin Sheng Xian Dai Nong Ye Chan Ye Ji Jin You Xian Gong Si	2201 Interest of corporation controlled by you
Ji Lin Sheng Nong Ye Tou Zi Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Zhong Guo Min Sheng Tou Zi Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Rationale (holdings) Investment Limited	2101 Beneficial owner
Zhong Min Xin Neng Tou Zi Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Rui Xuan Tou Zi Shang Hai You Xian Gong Si	2201 Interest of corporation controlled by you
Bank Of Jilin Co., Ltd.	2106 Person having a security interest in shares
Sun Zhen	2201 Interest of corporation controlled by you
Modern Agricultural Industry Investment Holdings Limited	2201 Interest of corporation controlled by you
Ji Lin Sheng Xian Dai Nong Ye Chan Ye Tou Zi Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you
Li Zhenghao	2201 Interest of corporation controlled by you

Global Bio-chem Technology Group Co (HKSE:00809) Headlines

No Headlines